564 related articles for article (PubMed ID: 8254829)
1. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
2. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
Borgmann V; al-Abadi H; Nagel R
Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
6. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
9. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
10. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
[TBL] [Abstract][Full Text] [Related]
11. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy of bladder cancer using bladder biopsy supernate specimens.
Loughman NT; Lin BP; Dent OF; Newland RC
Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
14. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
Sasaki K; Hamano K; Kinjo M; Hara S
Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis.
Corrado F; Ferri C; Mannini D; Corrado G; Bertoni F; Bacchini P; Lelli G; Lieber MM; Song JM
J Urol; 1991 Jun; 145(6):1159-63. PubMed ID: 2033684
[TBL] [Abstract][Full Text] [Related]
18. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.
Lee SH; Lin JS; Tzai TS; Chow NH; Tong YC; Yang WH; Chang CC; Cheng HL
Eur Urol; 1996; 29(3):266-70; discussion 271. PubMed ID: 8740029
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
